PubRank

Pasquale Niscola

Author PubWeight™ 45.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party. J Pain Symptom Manage 2013 2.20
2 Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report. Ann Hematol 2007 1.96
3 Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience. Leuk Lymphoma 2009 1.80
4 Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database. J Clin Oncol 2013 1.47
5 Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program. Indian J Palliat Care 2011 1.42
6 Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood 2006 1.26
7 Making quality of life assessment a dashboard for patient management. Support Care Cancer 2014 1.23
8 Pain and anxiety associated with bone marrow aspiration and biopsy: a prospective study on 152 Italian patients with hematological malignancies. Ann Hematol 2011 1.15
9 Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score. Support Care Cancer 2012 1.11
10 Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need. Support Care Cancer 2015 1.07
11 Disability and physical rehabilitation in patients with advanced hematological malignancies followed in a home care program. Support Care Cancer 2009 1.05
12 Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support Care Cancer 2013 1.02
13 Rapid loss of response after withdrawal of treatment with azacitidine: a case series in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Eur J Haematol 2013 0.97
14 Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 2012 0.96
15 Long-lasting remission induced by rituximab in two cases of refractory autoimmune haemolytic anaemia due to cold agglutinins. Blood Transfus 2009 0.94
16 Motor disability, clinical complications, quality of life, and survival in patients with cancer: a plausible scenario. Support Care Cancer 2014 0.91
17 Predicting survival in advanced hematologic malignancies: do patient-reported symptoms matter? Eur J Haematol 2012 0.89
18 Pure red cell aplasia associated with hemolytic anemia refractory to standard measures and resolved by rituximab in an elderly patient. Int J Hematol 2008 0.89
19 Cost analysis of a domiciliary program of supportive and palliative care for patients with hematologic malignancies. Haematologica 2007 0.88
20 Long-term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron Clin Pract 2009 0.86
21 Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes. Br J Haematol 2014 0.84
22 Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma. Support Care Cancer 2012 0.83
23 Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias. Am J Hematol 2015 0.83
24 Obstacles to adherence to azacitidine administration schedule in outpatient myelodysplastic syndrome and related disorders. Support Care Cancer 2014 0.82
25 NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. Ann Hematol 2014 0.82
26 Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence. Mediterr J Hematol Infect Dis 2013 0.82
27 Tattoo related pyoderma/ectyma gangrenous as presenting feature of relapsed acute myeloid leukaemia: an exceptionally rare observation. Injury 2011 0.82
28 Real-life experience with azacitidine in myelodysplastic syndromes according to IPSS cytogenetic profile. Am J Hematol 2014 0.81
29 Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera. Int J Hematol 2007 0.81
30 Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. Leuk Res 2009 0.81
31 Epidemiology and pathogenesis of incident pain-related disability in malignant hematology: an Italian survey. Ann Hematol 2010 0.79
32 Gingival myeloid sarcoma in myelodysplastic syndrome. Support Care Cancer 2013 0.78
33 Increased plasma levels of tacrolimus after ingestion of green tea. Am J Kidney Dis 2011 0.78
34 Motor disability in the setting of oral anticoagulant therapy. Int J Hematol 2011 0.78
35 Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience. Ann Hematol 2010 0.77
36 Effective pain management in hematological malignancies. Expert Rev Hematol 2009 0.77
37 Bone marrow aspiration and biopsy-related pain management. Ann Hematol 2013 0.77
38 Authors' reply. Indian J Palliat Care 2011 0.76
39 Cold autoimmune hemolytic anemia resolved by rituximab. Asian J Transfus Sci 2010 0.76
40 Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients. Infect Control Hosp Epidemiol 2011 0.76
41 Role of immunochemotherapy in the treatment of chronic lymphocytic leukemia. Expert Rev Anticancer Ther 2006 0.76
42 IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. Leuk Res 2009 0.76
43 Epidemiology of pain in hospital haematological setting: an Italian survey. Leuk Res 2007 0.76
44 [Membranous glomerulonephritis secondary to allogeneic stem cell transplant: review of the literature]. G Ital Nefrol 2012 0.76
45 Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case Report. Indian J Palliat Care 2011 0.75
46 Single versus double-unit transfusion policy in hematology. Haematologica 2012 0.75
47 Single-dose pegylated-filgrastim versus daily filgrastim after high-dose chemotherapy and autologous stem cell transplantation for lymphoid malignancies: delayed platelets recovery? Blood Transfus 2012 0.75
48 Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant. Support Care Cancer 2012 0.75
49 IgA-induced autoimmune hemolytic anemia in a patient with antiphospholipid syndrome. Asian J Transfus Sci 2012 0.75
50 Dysgeusia in patients with hematological malignancies: a reminder for hematologist. J Oral Pathol Med 2012 0.75
51 Sleep complaints in hospitalized Italian patients with hematological malignancies. Intern Med 2010 0.75
52 Necrotizing fasciitis in myelodysplastic syndrome: an exceptionally rare occurrence. Support Care Cancer 2012 0.75
53 Tapentadol PR for Pain Syndromes in Real Life Patients with Hematological Malignancy. Cardiovasc Hematol Agents Med Chem 2016 0.75
54 Pregnancy desire unmasks a MYH9 syndrome in a kidney transplant woman. Saudi J Kidney Dis Transpl 2012 0.75
55 Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma. Ann Hematol 2008 0.75
56 Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab-bendamustine regimen combined to hypomethylating therapy. J Chemother 2013 0.75
57 Primary MALT lymphoma of the upper lip mucosa: an exceptionally rare localisation. Int J Hematol 2008 0.75
58 Long-lasting remission of a relapsed large cell non-Hodgkin's lymphoma by Y90 ibritumomab tiuxetan as salvage therapy. Tumori 2009 0.75
59 High-dose epoetin alfa as induction treatment for severe anemia in multiple myeloma patients. Int J Hematol 2009 0.75
60 Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA). Ann Hematol 2010 0.75
61 Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview. Support Care Cancer 2010 0.75
62 Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes. Support Care Cancer 2013 0.75
63 Motor disability in end-stage renal failure: an epidemiological study on Italian dialyzed patients. Saudi J Kidney Dis Transpl 2011 0.75
64 Fever of unknown origin, anemia and thrombocytosis as early symptoms and signs of a late-onset polymialgia rheumatica: a diagnostic challenge. Ann Saudi Med 2012 0.75
65 Primitive "Spindle Cell Variant" (Sarcomatoid Variant) Diffuse Large B-Cell Lymphoma of the Uterine Cervix: Description and Outcome of a Rare Case. Int J Gynecol Pathol 2016 0.75
66 Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient. Leuk Res 2007 0.75
67 Isolated bone involvement of a single lumbar vertebra body as unusual presentation of relapsing Hodgkin's lymphoma. Acta Oncol 2009 0.75
68 Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab. Leuk Lymphoma 2007 0.75
69 Multicentric myeloid/NK sarcoma in an aleukemic patient evolved in refractory acute leukemia. Leuk Res 2009 0.75
70 Repeated rituximab maintenance courses in fludarabine-failed young patients with chronic lymphocytic leukaemia responding to FAND chemotherapy. Hematol J 2004 0.75
71 Unusual sequence of lymphoid disorders: follicular lymphoma subsequent to Hodgkin lymphoma and transformed into diffuse large B-cells non Hodgkin lymphoma. Acta Oncol 2009 0.75
72 Primary anaplastic large B-cell lymphoma in mandible: Long-term complete remission with R-CHOP regimen and involved field radiotherapy. Oral Oncol 2009 0.75
73 Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis. Cancer Chemother Pharmacol 2008 0.75
74 Drastic reduction of piperacillin-tazobactam concentrations in an in-vitro model of continuous venovenous hemofiltration: proposal of an innovative modality of administration to maintain them at constant concentration. Cardiovasc Hematol Agents Med Chem 2013 0.75
75 Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin's lymphoma patients. Ann Hematol 2007 0.75
76 Long term follow-up of a membranous glomerulopathy as late complication of chronic graft-versus-host disease following allogeneic stem cell transplantation. Int J Hematol 2008 0.75
77 Palliative sedation therapy in a bone marrow transplant unit. Support Care Cancer 2008 0.75
78 Rapid response and sustained remission by rituximab in four cases of plasma-exchange-failed acute thrombotic thrombocytopenic purpura. Int J Hematol 2009 0.75
79 Bortezomib-related colon mucositis in a multiple myeloma patient. Support Care Cancer 2009 0.75